Pharmacological management of post‐traumatic stress disorder and its associated nightmares: A survey of psychiatrists

Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review

“…1,2 Characteristic symptom domains include hyperarousal (heightened fear, irritability, sleep disturbance), re-experiencing (flashbacks, nightmares and reliving), and avoidance/numbing (inability to experience positive emotions and a feeling of detachment from others). [3][4][5] PTSD is often associated with significant levels of distress, major psychiatric and drug and alcohol comorbidities, reduced quality of life, and increased risk of mortality. 6,7 Evidence-based interventions for the treatment of PTSD include psychological therapies (such as cognitive behavioural therapy, cognitive processing therapy, exposure therapy, and eye movement desensitisation and reprocessing) and pharmacotherapy (fluoxetine, paroxetine, sertraline, and venlafaxine).…”